-->

Tag: PD-1 inhibitor

Home / PD-1 inhibitor

Categories

Penpulimab-kcqx is approved by the USFDA for non-keratinizing nasopharyngeal carcinoma

On April 23, 2025, the Food and Drug Administration sanctioned penpulimab-kcqx (Akeso Biopharma Co., Ltd.) in conjunction with cisplatin or carboplatin and gemcitabine for the initial treatment of peo...
pd-1-inhibitor

Roche PD-1 inhibitor liver cancer combination therapy was recognized by the FDA as a breakthrough therapy

The Swiss Roche Group announced yesterday that TECENTRIQ® (atezolizumab) in combination with Avastin® (bevacizumab) has been approved by the US Food and Drug Administration (FDA) for breakthrough th...
pd-1-inhibitor

Scan the code